{"id":"https://openalex.org/W112437951","doi":null,"title":"Physiologic mechanisms underlying the antidepressant discontinuation syndrome.","display_name":"Physiologic mechanisms underlying the antidepressant discontinuation syndrome.","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W112437951","mag":"112437951","pmid":"https://pubmed.ncbi.nlm.nih.gov/16683857"},"language":"en","primary_location":{"id":"pmid:16683857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16683857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002538047","display_name":"Pierre Blier","orcid":"https://orcid.org/0000-0002-9196-0706","observed_orcids":["https://orcid.org/0000-0002-9196-0706","https://orcid.org/0000-0003-1881-2421"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I4405262572","display_name":"Institute of Mental Health Research","ror":"https://ror.org/042cm9p56","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I153718931","https://openalex.org/I4405262572"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Pierre Blier","raw_affiliation_strings":["Department of Psychiatry, Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I4405262572"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103390100","display_name":"Philippe Tremblay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Tremblay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9027,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.84027115,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"67 Suppl 4","issue":null,"first_page":"8","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressant-discontinuation-syndrome","display_name":"antidepressant discontinuation syndrome","score":0.9919999837875366},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.7139999866485596},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cholinergic-system","display_name":"cholinergic system","score":0.9900000095367432},{"id":"https://openalex.org/keywords/neurotransmitter-interactions","display_name":"neurotransmitter interactions","score":0.7070000171661377},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5730000138282776},{"id":"https://openalex.org/keywords/mood-disorders","display_name":"mood disorders","score":0.7429999709129333},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.9580000042915344},{"id":"https://openalex.org/keywords/antidepressant-mechanism-of-action","display_name":"antidepressant mechanism","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.959084153175354},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6684086322784424},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5401633381843567},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.534991443157196},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.49291539192199707},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.4452025592327118},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4044557809829712},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3932664692401886},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.37351739406585693},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21916168928146362},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.19059321284294128}],"mesh":[{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D013577","descriptor_name":"Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019964","descriptor_name":"Mood Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16683857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16683857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Comparative Study"},{"id":"mag:112437951","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16683857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7016244330","https://openalex.org/W150138163","https://openalex.org/W2242959703","https://openalex.org/W2402630593","https://openalex.org/W2098260262","https://openalex.org/W2032519777","https://openalex.org/W1965526627","https://openalex.org/W7098769453","https://openalex.org/W2472150561","https://openalex.org/W2018790154"],"abstract_inverted_index":{"The":[0,25],"rate":[1],"at":[2,158],"which":[3,54],"serotonin":[4,73],"reuptake":[5],"inhibitor":[6],"(SRI)":[7],"treatment":[8,15,77],"is":[9,61],"terminated":[10],"and":[11,143,167,193],"the":[12,32,69,96,111,119,134,139,150,162,165,168,171,184],"duration":[13],"of":[14,27,34,45,53,105,121,129,161,187],"appear":[16,83],"to":[17,30,117,155,179],"be":[18,89],"key":[19],"factors":[20],"in":[21,57,72,110,183,189],"predicting":[22],"discontinuation":[23,50,64,85,141],"symptoms.":[24],"development":[26],"animal":[28],"models":[29],"explain":[31,118,180],"mechanisms":[33],"this":[35,122],"clinical":[36],"problem":[37],"has":[38],"proved":[39],"challenging,":[40],"because":[41],"less":[42],"than":[43],"half":[44],"all":[46],"patients":[47,190],"experience":[48],"any":[49],"symptoms,":[51],"many":[52],"are":[55],"subjective":[56],"nature.":[58],"One":[59],"explanation":[60],"that":[62,84],"SRI":[63],"symptoms":[65],"may":[66,87],"arise":[67],"from":[68],"rapid":[70],"decrease":[71],"(5-HT)":[74],"availability":[75],"when":[76],"ends":[78],"abruptly.":[79],"Yet,":[80],"it":[81],"would":[82],"discomforts":[86],"not":[88],"mediated":[90],"exclusively":[91],"through":[92],"5-HT":[93,100],"receptors,":[94],"given":[95],"major":[97],"regulatory":[98],"role":[99],"exerts":[101],"on":[102,125],"a":[103,114,126],"number":[104],"specific":[106],"chemical":[107],"receptor":[108],"systems":[109,152],"brain.":[112],"As":[113],"result,":[115],"attempts":[116,178],"determinants":[120],"phenomenon":[123],"rely":[124],"certain":[127],"level":[128],"speculation.":[130],"This":[131],"article":[132],"examines":[133],"possible":[135,172],"physiologic":[136],"bases":[137],"for":[138,157],"antidepressant":[140],"syndrome":[142],"briefly":[144],"describes":[145],"these":[146],"adaptations.":[147],"It":[148,176],"discusses":[149],"3":[151],"most":[153],"likely":[154],"account":[156],"least":[159],"part":[160],"symptomatology--the":[163],"5-HT,":[164],"norepinephrine,":[166],"cholinergic":[169],"systems--and":[170],"interactions":[173],"among":[174],"them.":[175],"also":[177],"their":[181],"implications":[182],"therapeutic":[185],"actions":[186],"antidepressants":[188],"with":[191],"affective":[192],"anxiety":[194],"disorders.":[195]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}